Sonoma Pharmaceuticals (SNOA) EBT Margin (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly EBT Margin of 8.94% for Q1 2026, up 513.0% year-over-year from 1.46% in Q1 2025, and up 59.04% quarter-over-quarter from 21.82% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) EBT Margin (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 8.94% for Q1 2026.
- In Q1 2026, EBT Margin rose 513.0% year-over-year to 8.94%; the TTM figure through Mar 2026 stood at 17.51% (up 284.0% YoY), while the FY2026 annual figure was 17.51%, up 284.0% from the prior year.
- EBT Margin for Q1 2026 stood at 8.94%, up from 21.82% in the prior quarter.
- The five-year high for EBT Margin was 8.94% in Q1 2026, with the low at 142.82% in Q1 2022.
- The 5-year median for EBT Margin is 29.4% (2024), against an average of 36.57%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 3218 bps in 2022, then jumped 9508 bps in 2023.
- Sonoma Pharmaceuticals' EBT Margin stood at 64.71% in 2022, then surged by 55 bps to 29.41% in 2023, then rose by 12 bps to 25.79% in 2024, then advanced by 15 bps to 21.82% in 2025, then jumped by 59 bps to 8.94% in 2026.
- Business Quant data shows SNOA's EBT Margin at 8.94% in Q1 2026, 21.82% in Q4 2025, and 13.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | -5.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.15% |
| Mar 31, 2026 | -8.94% |
| Dec 31, 2025 | -21.82% |
| Sep 30, 2025 | -13.04% |
| Jun 30, 2025 | -30.93% |
| Mar 31, 2025 | -14.06% |
| Dec 31, 2024 | -25.79% |
| Sep 30, 2024 | -12.94% |
| Jun 30, 2024 | -29.40% |
| Mar 31, 2024 | -39.52% |
| Dec 31, 2023 | -29.41% |
| Sep 30, 2023 | -47.53% |
| Jun 30, 2023 | -42.34% |
| Mar 31, 2023 | -47.74% |
| Dec 31, 2022 | -64.71% |
| Sep 30, 2022 | -27.53% |
| Jun 30, 2022 | -23.15% |
| Mar 31, 2022 | -142.82% |
| Dec 31, 2021 | -32.53% |
| Sep 30, 2021 | -2.54% |